Comments Welcome on the Updated Pediatric Treatment Guidelines
The latest version of the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection was released on February 28, 2008. The updated guidelines are available for download from the Pediatric Guidelines section of AIDSinfo. You can also order them by mail or e-mail from AIDSinfo's Order Publications section.
Your Feedback Is Important!
The Pediatric Antiretroviral Guidelines Working Group would like to hear your feedback on the latest revisions to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Please send your comments with the subject line "Pediatric Comments" to AIDSinfoWebmaster@aidsinfo.nih.gov by March 13, 2008.
Microbicidal Gel Shown to Be Safe in HIV-Uninfected Women
Researchers in the United States and India have determined that a tenofovir-based microbicidal gel is safe for HIV-uninfected women to use daily to prevent transmission of HIV.
The 6-month study, conducted by the NIH's Microbicide Trials Network, included 200 women from India and the United States. There were no differences seen in adverse events between women using the tenofovir-based gel compared to women using a placebo. Adherence was approximately 80% and none of the women in the study became infected with HIV while using the tenofovir-based gel.
More information is available:
- MedlinePlus: Full Story
- AIDSinfo: Tenofovir drug fact sheet
- AIDSinfo: Investigational Microbicides
- AIDSinfo: Microbicide Health Topics